Search

everythinglearnresearchcommunity

for

Search:↓

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Some alternative treatments for vitiligo show promise but need more research to confirm their safety and effectiveness.

Donors on most medications can donate certain blood products without waiting, except for specific drugs that need a waiting period.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Better diagnostic tools and treatment guidelines are needed for segmental vitiligo and related pigment issues.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Individualized treatments may help manage Dercum's disease symptoms.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Six African American women experienced hair loss after switching to a new HIV medication.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

In 2023, there were major advancements in skin and venereal disease treatments.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.

Antibody treatments show promise for hair loss but need more research.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Combining oral minoxidil and bicalutamide may help improve hair growth in adolescent girls.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

A vibrating anesthetic device significantly reduces pain during mesotherapy for hair loss without complications.